3/15
11:02 pm
plx
Protalix BioTherapeutics, Inc. (NYSE: PLX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Medium
Report
Protalix BioTherapeutics, Inc. (NYSE: PLX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
3/15
01:30 pm
plx
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/14
06:56 am
plx
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results [Yahoo! Finance]
Medium
Report
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results [Yahoo! Finance]
3/14
06:50 am
plx
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results
Medium
Report
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results
3/7
07:03 am
plx
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024 [Yahoo! Finance]
Low
Report
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024 [Yahoo! Finance]
3/7
06:50 am
plx
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024
Low
Report
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024
2/23
07:01 am
plx
Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference [Yahoo! Finance]
Low
Report
Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference [Yahoo! Finance]
2/23
06:50 am
plx
Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference
Low
Report
Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference
1/25
02:16 pm
plx
Plant-based Vaccines Market Industry Analysis and Forecast to 2031 - Promising Avenue for Safer, More Accessible and Cost-Effective Vaccine Development [Yahoo! Finance]
Neutral
Report
Plant-based Vaccines Market Industry Analysis and Forecast to 2031 - Promising Avenue for Safer, More Accessible and Cost-Effective Vaccine Development [Yahoo! Finance]
1/24
04:01 am
plx
Glycomic Therapeutics Market is Projected to Reach US$551,756 Million by 2032, at a CAGR of 16.1% from 2023 to 2032 | Persistence Market Research [Yahoo! Finance]
Medium
Report
Glycomic Therapeutics Market is Projected to Reach US$551,756 Million by 2032, at a CAGR of 16.1% from 2023 to 2032 | Persistence Market Research [Yahoo! Finance]